Figure 3
sCD30 levels (ng/mL) in patients with aGVHD compared with patients without (NONE). Patients with aGVHD had a median of 61.7 ng/mL (range, 9.8-357.1) of sCD30 compared with a median of 17.4 ng/mL (3.7-142.4) in the control group, P < .001.
sCD30 levels (ng/mL) in patients with aGVHD compared with patients without (NONE). Patients with aGVHD had a median of 61.7 ng/mL (range, 9.8-357.1) of sCD30 compared with a median of 17.4 ng/mL (3.7-142.4) in the control group, P < .001.
